Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

2.51
Delayed Data
As of Apr 01
 +0.04 / +1.62%
Today’s Change
2.40
Today|||52-Week Range
15.00
-57.39%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close2.47
Today’s open2.43
Day’s range2.40 - 2.66
Volume215,450
Average volume (3 months)286,107
Market cap$87.6M
Dividend yield--
Data as of 4:00pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)+93.80%
Earnings growth (this year)-80.85%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp-0.09-2.43%
AQXPAquinox Pharmaceutic...+0.06+0.73%
LPCNLipocine Inc-0.16-2.32%
MNOVMediciNova Inc+0.05+1.43%
Data as of 4:00pm ET, 04/01/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$10.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Chief Operating &
Medical Officer
Dragan Cicic
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account